Literature DB >> 8071320

Crystallographic structure of human gamma-thrombin.

T J Rydel1, M Yin, K P Padmanabhan, D T Blankenship, A D Cardin, P E Correa, J W Fenton, A Tulinsky.   

Abstract

In an effort to prepare crystals and determine the structure of alpha-thrombin complexed to a synthetic peptide inhibitor (MDL-28050) of the hirudin 54-65 COOH-terminal region, it was discovered that the crystals were not those of the complex but of gamma-thrombin. Gel electrophoresis studies revealed that autolytic degradation had occurred prior to crystallization. NH2-terminal sequence analysis of these autolytic fragments confirmed the gamma-thrombin product (cleavages at Arg75-Tyr76 and/or Arg77A-Asn78, and Lys149E-Gly150; chymotrypsinogen numbering) with a minor amount of another autolysis product, beta-thrombin (first two cleavages only). The final structure has an R-factor of 0.156 for 7.0-2.5-A data, and includes 186 water molecules. A comparison of gamma-thrombin with the thrombin structure in the alpha-thrombin-hirugen complex revealed that the two structures agreed well (r.m.s. delta = 0.39 A for main chain atoms). These structures possess uninhibited active sites where the disposition of the catalytic triad residues is nearly identical. The electron density in the vicinity of the gamma-thrombin cleavage regions is poor, and only becomes well-defined several residues prior to and after the actual cleavage sites. The extensive disorder evoked by beta-cleavage(s) in the Lys70-Glu80 loop region indicates that this part of the molecule is severely disrupted by autolysis and is the reason exosite functions are dramatically impaired in beta-and gamma-thrombin. Since autolysis did not lead to a major reorganization of the folded structure of alpha-thrombin, the likely structural features of the interaction of thrombin substrate with thrombin enzyme during beta-cleavage have been modeled by docking the exosite region of one molecule at the active site of another.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071320

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Comparison of the active-site conformations of bovine alpha-thrombin and meizothrombin(desF1) by electron spin resonance.

Authors:  P D Boxrud; L J Berliner
Journal:  J Protein Chem       Date:  1996-02

2.  Plasmin-mediated proteolysis of human factor IXa in the presence of calcium/phospholipid: Conversion of procoagulant factor IXa to a fibrinolytic enhancer.

Authors:  Amy E Schmidt; Kanagasabai Vadivel; Julian Whitelegge; Satya Paul Bajaj
Journal:  J Thromb Haemost       Date:  2020-03-30       Impact factor: 5.824

3.  Aggregation of thrombin-derived C-terminal fragments as a previously undisclosed host defense mechanism.

Authors:  Jitka Petrlova; Finja C Hansen; Mariena J A van der Plas; Roland G Huber; Matthias Mörgelin; Martin Malmsten; Peter J Bond; Artur Schmidtchen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-04       Impact factor: 11.205

4.  Inhibition of thrombin activity by prothrombin activation fragment 1.2.

Authors:  Swapan Kumar Dasgupta; Perumal Thiagarajan
Journal:  J Thromb Thrombolysis       Date:  2007-03-02       Impact factor: 2.300

5.  Polyphosphate binds with high affinity to exosite II of thrombin.

Authors:  N J Mutch; T Myles; L L K Leung; J H Morrissey
Journal:  J Thromb Haemost       Date:  2009-12-11       Impact factor: 5.824

6.  The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.

Authors:  J Vijayalakshmi; K P Padmanabhan; K G Mann; A Tulinsky
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

Review 7.  Thrombin domains: structure, function and interaction with platelet receptors.

Authors:  Raimondo De Cristofaro; Erica De Candia
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

8.  Cloning and characterization of human protease-activated receptor 4.

Authors:  W F Xu; H Andersen; T E Whitmore; S R Presnell; D P Yee; A Ching; T Gilbert; E W Davie; D C Foster
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

9.  Mapping specificity, cleavage entropy, allosteric changes and substrates of blood proteases in a high-throughput screen.

Authors:  Federico Uliana; Matej Vizovišek; Laura Acquasaliente; Rodolfo Ciuffa; Andrea Fossati; Fabian Frommelt; Sandra Goetze; Bernd Wollscheid; Matthias Gstaiger; Vincenzo De Filippis; Ulrich Auf dem Keller; Ruedi Aebersold
Journal:  Nat Commun       Date:  2021-03-16       Impact factor: 14.919

10.  Identification and Mechanistic Analysis of a Novel Tick-Derived Inhibitor of Thrombin.

Authors:  Willy Jablonka; Michalis Kotsyfakis; Daniella M Mizurini; Robson Q Monteiro; Jan Lukszo; Steven K Drake; José M C Ribeiro; John F Andersen
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.